2023
Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart disease
Kalra K, Moumneh M, Nanna M, Damluji A. Beyond MACE: a multidimensional approach to outcomes in clinical trials for older adults with stable ischemic heart disease. Frontiers In Cardiovascular Medicine 2023, 10: 1276370. PMID: 38045910, PMCID: PMC10690830, DOI: 10.3389/fcvm.2023.1276370.Peer-Reviewed Original ResearchStable ischemic heart diseaseIschemic heart diseaseClinical trialsOlder adult populationOlder adultsHeart diseaseHealth outcomesAdult populationMajor adverse cardiovascular outcomesHigh cardiovascular riskAdverse cardiovascular outcomesMultiple chronic diseasesPatient-centered approachCardiovascular clinical trialsPoor health outcomesMore effective careQuality of lifeHolistic health outcomesCardiovascular outcomesCardiovascular riskGeriatric syndromesRandomized trialsPatient populationPatient preferencesChronic diseasesAssessment and Management of Older Adults Undergoing PCI, Part 1 A JACC: Advances Expert Panel
Nanna M, Sutton N, Kochar A, Rymer J, Lowenstern A, Gackenbach G, Hummel S, Goyal P, Rich M, Kirkpatrick J, Krishnaswami A, Alexander K, Forman D, Bortnick A, Batchelor W, Damluji A, Councils A. Assessment and Management of Older Adults Undergoing PCI, Part 1 A JACC: Advances Expert Panel. JACC Advances 2023, 2: 100389. PMID: 37584013, PMCID: PMC10426754, DOI: 10.1016/j.jacadv.2023.100389.Peer-Reviewed Original ResearchHigh-risk percutaneous coronary interventionOlder adultsProportion of patientsPercutaneous coronary interventionHigh-risk groupCardiac catheterization laboratoryConventional risk assessment toolsRisk assessment toolCardiovascular riskCoronary interventionGeriatric syndromesGeriatric domainsCardiovascular SocietyProcedural riskCatheterization laboratoryHemodynamic riskPopulation agesDisproportionate riskExpert panelStructured risk assessmentPatientsRiskAdultsAssessment toolMorbidityHierarchical Development of Physical Frailty and Cognitive Impairment and Their Association With Incident Cardiovascular Disease
Damluji A, Ijaz N, Chung S, Xue Q, Hasan R, Batchelor W, Orkaby A, Kochar A, Nanna M, Roth D, Walston J, Resar J, Gerstenblith G. Hierarchical Development of Physical Frailty and Cognitive Impairment and Their Association With Incident Cardiovascular Disease. JACC Advances 2023, 2: 100318. PMID: 37538136, PMCID: PMC10399211, DOI: 10.1016/j.jacadv.2023.100318.Peer-Reviewed Original ResearchMajor adverse cardiovascular eventsAdverse cardiovascular eventsCognitive impairmentCardiovascular eventsCardiovascular outcomesCardiovascular riskCardiovascular diseaseIncident major adverse cardiovascular eventsOlder adultsAdverse cardiovascular outcomesIncident cardiovascular diseasePhysical frailty phenotypeCoronary artery diseaseMultiple chronic conditionsPoor health outcomesAging Trends StudyFrailty phenotypeArtery diseasePrimary outcomeGeriatric conditionsChronic conditionsNational HealthPhysical frailtyStudy populationHigh risk
2019
THE IMPACT OF HYPERLIPIDEMIA ON CARDIOVASCULAR RISK IN OLDER ADULTS AGE ≥ 75: RESULTS FROM THE NHLBI POOLED COHORTS
Nanna M, Navar A, Wojdyla D, Peterson E. THE IMPACT OF HYPERLIPIDEMIA ON CARDIOVASCULAR RISK IN OLDER ADULTS AGE ≥ 75: RESULTS FROM THE NHLBI POOLED COHORTS. Journal Of The American College Of Cardiology 2019, 73: 1693. DOI: 10.1016/s0735-1097(19)32299-5.Peer-Reviewed Original Research
2018
Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry
Nanna MG, Navar AM, Zakroysky P, Xiang Q, Goldberg AC, Robinson J, Roger VL, Virani SS, Wilson PWF, Elassal J, Lee LV, Wang TY, Peterson ED. Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use: Insights From the Patient and Provider Assessment of Lipid Management Registry. JAMA Cardiology 2018, 3: 739-748. PMID: 29898219, PMCID: PMC6656582, DOI: 10.1001/jamacardio.2018.1511.Peer-Reviewed Original ResearchMeSH KeywordsAgedAtherosclerosisAttitude to HealthBlack or African AmericanCholesterol, LDLFemaleGuideline AdherenceHealthcare DisparitiesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperlipidemiasMaleMiddle AgedPerceptionPrimary PreventionRegistriesRiskSecondary PreventionSocial ClassUnited StatesWhite PeopleConceptsAfrican American patientsAfrican American individualsStatin therapyStatin useWhite individualsAmerican patientsPatients' beliefsProvider assessmentCardiology/American Heart Association guidelinesMedian low-density lipoprotein (LDL) cholesterol levelLow-density lipoprotein cholesterol levelsGuideline-recommended statin therapyAtherosclerotic cardiovascular disease riskAmerican Heart Association guidelinesGuideline-recommended intensityLipid Management (PALM) registryHeart Association guidelinesLipoprotein cholesterol levelsCardiovascular disease riskAmerican individualsCommunity health care practicesClinician differencesHealth care practicesPALM registryCardiovascular risk